Drug Shortage Report for MYLAN-RISPERIDONE ODT
| Report ID | 3360 |
| Drug Identification Number | 02413485 |
| Brand name | MYLAN-RISPERIDONE ODT |
| Common or Proper name | RISPERIDONE ODT |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RISPERIDONE |
| Strength(s) | 0.5MG |
| Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | ORAL |
| Packaging size | 100BT |
| ATC code | N05AX |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2017-04-24 |
| Estimated end date | Unknown |
| Actual end date | 2021-11-15 |
| Shortage status | Resolved |
| Updated date | 2021-11-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v51 | 2021-11-23 | French | Compare |
| v50 | 2021-11-23 | English | Compare |
| v49 | 2020-01-09 | French | Compare |
| v48 | 2020-01-09 | English | Compare |
| v47 | 2019-02-21 | French | Compare |
| v46 | 2019-02-21 | English | Compare |
| v45 | 2018-11-06 | French | Compare |
| v44 | 2018-11-06 | English | Compare |
| v43 | 2018-10-03 | French | Compare |
| v42 | 2018-10-03 | English | Compare |
| v41 | 2018-08-28 | French | Compare |
| v40 | 2018-08-28 | English | Compare |
| v39 | 2018-07-25 | French | Compare |
| v38 | 2018-07-25 | English | Compare |
| v37 | 2018-07-16 | French | Compare |
| v36 | 2018-07-16 | English | Compare |
| v35 | 2018-05-23 | French | Compare |
| v34 | 2018-05-23 | English | Compare |
| v33 | 2018-05-18 | French | Compare |
| v32 | 2018-05-18 | English | Compare |